A previous study reported that the expression of phospho-tau (serine 202/threonine 205) in AD brains could predict the stage of tau pathology and these tau sites are phosphorylated by various kinases, such as GSK-3β and cyclin-dependent kinase 5 [55, 56]. This evidence concerns the gene CDK5 and Alzheimer disease.